We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRHI:NASDAQPresurance Holdings, Inc. Analysis

Data as of 2026-04-25 - not real-time

$0.66

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Presurance Holdings trades at $0.66, well below its 20‑day (≈$0.68) and 50‑day (≈$0.69) simple moving averages, confirming a bearish technical outlook. The MACD is in a bearish configuration and the RSI sits near the neutral 48 level, offering little upside momentum. Volatility is extreme at over 160% on a 30‑day basis and volume is on a decreasing trend, underscoring fragile market participation. Fundamentally, the company posted a 52.8% revenue decline, negative gross (‑27%) and operating margins (‑210%), and a trailing EPS of –$1.51, indicating a deep earnings hole. Despite a cash pile of $52 M, total debt of $26.7 M and a debt‑to‑equity ratio near 300% raise solvency concerns, while the price‑to‑book of 0.90 and price‑to‑sales of 0.46 suggest the stock is priced below its asset base. No dividend is paid, and the ROE and ROA are both strongly negative. Recent news reveals the CEO’s $71,810 share purchase but also highlights that PRHI has remained under $1 for 30 consecutive days, jeopardizing Nasdaq compliance and exposing a delisting risk that must be resolved by August 2026. The combination of deteriorating fundamentals, high volatility, and regulatory pressure points to a high‑risk, value‑oriented play.
Given these dynamics, the stock appears markedly undervalued relative to its book and sales metrics, yet the upside is constrained by operational losses, capital structure strain, and the looming exchange‑listing issue, making any investment speculative at best.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • Bearish price action below key moving averages
  • Nasdaq compliance threat and potential delisting
  • Severe earnings losses and negative margins

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential for balance‑sheet restructuring using cash reserves
  • Low price‑to‑book offering a margin of safety if turnaround occurs
  • Continued high volatility and weak operating cash flow

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Asset‑light structure with substantial cash relative to market cap
  • Undervalued relative to book and sales multiples
  • Opportunity for strategic acquisition or niche market recovery

Key Metrics & Analysis

Financial Health

Revenue Growth-52.80%
Profit Margin-49.72%
ROE-120.94%
ROA-5.12%
Debt/Equity297.64
P/B Ratio0.9
Op. Cash Flow$-43882000
Free Cash Flow$-129439128
Industry P/E17.3

Technical Analysis

TrendBearish
RSI48.1
Support$0.48
Resistance$0.85
MA 20$0.68
MA 50$0.69
MA 200$0.92
MACDBearish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.97
Volatility164.76%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.